Please login to the form below

Not currently logged in
Email:
Password:

PR company appoints new UK head

Chamberlain Healthcare Public Relations has appointed Mark John Cater as managing director of its London office

Chamberlain Healthcare Public Relations, an inVentiv Health company, has appointed Mark John Cater as managing director of its London office.

Prior to joining Chamberlain, Cater was regional director, Europe, Middle East, Africa and India for Cohn & Wolfe, and chief executive officer of GCI UK before the company merged in 2008 with Cohn & Wolfe. He also spent six years in various leadership roles as partner and director at public relations agency Ketchum, where he was responsible for the company's worldwide healthcare practice and served in both the London and New York offices.  

"Given our brief tenure but serious intentions in London, it is important we attract the best leadership," said Richard Chamberlain, the agency's president. "Mark's 22 years of public relations experience in both the public and private sectors across the UK, European and the US markets makes him exceptionally qualified to lead our London team, support our worldwide clients and further our global communications efforts." 

Chamberlain Healthcare Public Relations serves the healthcare sector exclusively. Operating in London since 2008, the firm works on behalf of several US-based, worldwide pharmaceutical clients on their global brands and issues.

 

4th January 2010

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

How innovating study sites can improve patient recruitment efficiency
There are so many ways that clinical trials have innovated over the last few years. There is now a larger focus on making trials more patient-centric, more virtualised, and more...
PME-MAY21-Cover
Avoiding A Series of Unfortunate Events: launch lessons from lockdown
Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
6 reasons patients drop out of clinical trials and 6 ways to fix it
If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....